Prevention of atrial fibrillation
135 results
101 - 135
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation- Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack: Cochrane systematic review
Transient ischaemic attack (TIA) - Antithrombotic agents in primary health care
- Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
Niacin not effective in CAD with low HDL cholesterol (AIM-HIGH)- Anticoagulants versus antiplatelet agents for acute ischaemic stroke: Cochrane systematic review
- Discontinuing warfarin therapy indefinitely after GI bleeding assoc with worse outcomes
- Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
- Prevention of venous thromboembolism
- Preoperative statin therapy for adults undergoing cardiac surgery
- Comparable benefits and harms of anticoagulant and antiplatelet treatment in patients with PFO and cryptogenic stroke
- Antiplatelet and anticoagulation for patients with prosthetic heart valves
- Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
- 2023 American Geriatric Society update on potentially inappropriate medication use in the elderly (Beers List)
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery
- Cerebral infarction (ischaemic stroke)
- Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery
- Icosapent ethyl reduces risk of CV death in patients with CV disease, low LDL, and high triglycerides (REDUCE-IT)
- Antiplatelet therapy for prevention of death, myocardial infarction, and stroke
- Colchicine for the primary prevention of cardiovascular events
- Anticoagulants for people hospitalised with COVID‐19
- Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
- Lumbar puncture
- Preoperative assessment
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Natriuretic peptide‐guided treatment for the prevention of cardiovascular events in patients without heart failure
- Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults: Cochrane systematic review
- Deep vein thrombosis